Category: Research News
New research has identified the specific brain cells that control how much sugar you eat and how much you crave sweet tasting food. Most people enjoy a sweet treat …
An experimental antibody drug that targets one of the body's key metabolism regulators may help obese people lose weight—at least briefly.
The Food and Drug Administration’s new indication for liraglutide (Saxenda) for weight loss in adolescents with obesity, announced on Dec. 4, received welcome as a milestone for advancing a field that’s seen no new …
The positive benefits of breakfast in weight loss has been the long-held beliefs and widespread medical recommendations of many. Despite this we have reasons to think that breakfast does …
In a phase 3 trial where all participants received intensive behavior therapy, investigational 2.4-mg once-weekly subcutaneous semaglutide (Novo Nordisk) resulted in a 10.3% greater average weight loss than placebo over a …
A year of subcutaneous daily Saxenda injection plus exercise was superior to placebo or saxenda or exercise alone in maintaining weight loss, in a new study. (Liraglutide) Saxenda Injection …
NEW YORK (Reuters Health) – A new study on Saxenda as a weight-loss treatment for obese adolescents has concluded that it can reduce BMI by at least 5% in …